Hepatitis B screening among asylum seekers: a retrospective cohort study in Modena, Northern Italy.
5 affiliations
- 1Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
- 2Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
- 3Public Hygiene Service, Department of Public Health, AUSL Modena, Modena, Italy.
- 4Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States.
- 5School of Public Health, University of California Berkeley, Berkeley, CA, United States.
Abstract
Hepatitis B virus remains a major health challenge among migrants from high-endemic regions arriving in low-endemic countries like Italy. However, more evidence on both infection burden and immunity gaps among asylum seekers is needed to inform prevention policies. We conducted a retrospective cohort study of 739 asylum seekers screened for Hepatitis B virus (HBV) in Modena, Northern Italy, between 2019 and 2023. Serological testing included quantitative determination of HBsAg, HBcAb, and HBsAb, allowing identification of active infection, natural immunity, vaccine-induced immunity, and susceptibility. Demographic characteristics, geographic origin, and migration routes were analyzed in relation to HBV status. Participants were predominantly male (94.7%), with a mean age of 27.2 years, and originated mainly from South Asia (59.4%) and Sub-Saharan Africa (26.1%). Overall HBsAg prevalence was 4.1%, substantially higher than what reported for the Italian general population (<1%). Prevalence was highest among Sub-Saharan African migrants (7.3%), who also showed the greatest proportion of natural immunity (36.3%), while South Asian migrants had a prevalence of 3.6% and Northern African migrants null. Among HBsAg-negative individuals, 57% were susceptible to HBV infection, particularly those from South Asia and Northern Africa. Susceptibility was associated with male sex (OR 4.08, 95% CI 1.34-12.44) and age ≥25 years (OR 2.38, 95% CI 1.40-4.04), consistent with birth before the introduction of universal HBV vaccination in many countries. Most HBsAg-positive individuals reported transit through Libya. Asylum seekers in Italy show a high prevalence of HBV infection alongside substantial immunity deficits. Systematic screening and targeted catch-up vaccination should be prioritized within migrant health services as a key public health intervention.
Related
- Barriers and facilitators to healthcare access among asylum seekers: a systematic review
- Complex post-traumatic stress disorder in refugees, asylum seekers, and internally displaced people: a systematic review and meta-analysis.
- Development and internal validation of a nomogram-based screening tool for concurrent autoimmune hepatitis in children with intestinal diseases: a retrospective cohort study.
- Prevalence of screening markers for HIV, hepatitis B virus, hepatitis C virus, and syphilis and associated factors among voluntary non-remunerated blood donors in Addis Ababa, Ethiopia: a cross-sectional study
- Hepatitis C screening strategies and linkage-to-care approaches in U.S. emergency departments: A systematic review and meta-analysis
BibTeX
@article{mazzoli2026hepatitis,
title = {{Hepatitis B screening among asylum seekers: a retrospective cohort study in Modena, Northern Italy.}},
author = {Riccardo Mazzoli and Lucia Borsari and Maria La Torre and Zaynalabedin Kahfian and Alessandra Fantuzzi and Marco Vinceti and Annalisa Bargellini and Tommaso Filippini and Stefania Paduano},
journal = {European journal of public health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag188},
url = {https://europepmc.org/article/MED/42907096},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hepatitis B screening among asylum seekers: a retrospective cohort study in Modena, Northern Italy.
AU - Riccardo Mazzoli
AU - Lucia Borsari
AU - Maria La Torre
AU - Zaynalabedin Kahfian
AU - Alessandra Fantuzzi
AU - Marco Vinceti
AU - Annalisa Bargellini
AU - Tommaso Filippini
AU - Stefania Paduano
PY - 2026
DA - 2026/10/01
JO - European journal of public health
DO - 10.1093/eurpub/ckag188
UR - https://europepmc.org/article/MED/42907096
AB - Hepatitis B virus remains a major health challenge among migrants from high-endemic regions arriving in low-endemic countries like Italy. However, more evidence on both infection burden and immunity gaps among asylum seekers is needed to inform prevention policies. We conducted a retrospective cohort study of 739 asylum seekers screened for Hepatitis B virus (HBV) in Modena, Northern Italy, between 2019 and 2023. Serological testing included quantitative determination of HBsAg, HBcAb, and HBsAb, allowing identification of active infection, natural immunity, vaccine-induced immunity, and susceptibility. Demographic characteristics, geographic origin, and migration routes were analyzed in relation to HBV status. Participants were predominantly male (94.7%), with a mean age of 27.2 years, and originated mainly from South Asia (59.4%) and Sub-Saharan Africa (26.1%). Overall HBsAg prevalence was 4.1%, substantially higher than what reported for the Italian general population (<1%). Prevalence was highest among Sub-Saharan African migrants (7.3%), who also showed the greatest proportion of natural immunity (36.3%), while South Asian migrants had a prevalence of 3.6% and Northern African migrants null. Among HBsAg-negative individuals, 57% were susceptible to HBV infection, particularly those from South Asia and Northern Africa. Susceptibility was associated with male sex (OR 4.08, 95% CI 1.34-12.44) and age ≥25 years (OR 2.38, 95% CI 1.40-4.04), consistent with birth before the introduction of universal HBV vaccination in many countries. Most HBsAg-positive individuals reported transit through Libya. Asylum seekers in Italy show a high prevalence of HBV infection alongside substantial immunity deficits. Systematic screening and targeted catch-up vaccination should be prioritized within migrant health services as a key public health intervention.
SN - 1101-1262
SN - 1464-360X
ER -